Скачать или смотреть CRI 2024 Award Gala | Dr. Andrea Schietinger Frederick W. Alt Award Acceptance Speech

Andrea Schietinger, PhD, Principal Investigator and Member of the Memorial Sloan Kettering Cancer Center, accepts the 2024 Frederick W. Alt Award for New Discoveries in Immunology. A CRI Lloyd J. Old STAR, Dr. Schietinger’s groundbreaking research is transforming our understanding of how tumors interact with the immune system in the tissue microenvironment. This award honors her tremendous success in advancing the field of immunology, recognizing her as a former CRI postdoctoral fellow whose discoveries are making a significant impact. Learn about the innovative work driving new approaches to cancer immunotherapy and what’s next on her horizon.
--
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. https://www.cancerresearch.org

Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.